Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Jiang-Man Zhao"'
Autor:
Jiang-Man Zhao, Zhi-Hui Su, Qiu-Ying Han, Miao Wang, Xin Liu, Jing Li, Shao-Yi Huang, Jing Chen, Xiao-Wei Li, Xia-Ying Chen, Zeng-Lin Guo, Shuai Jiang, Jie Pan, Tao Li, Wen Xue, Tao Zhou
Publikováno v:
Nutrition & Metabolism, Vol 21, Iss 1, Pp 1-13 (2024)
Abstract Background Type 1 diabetes is believed to be an autoimmune condition, characterized by destruction of insulin-producing cells, due to the detrimental inflammation in pancreas. Growing evidences have indicated the important role of type I int
Externí odkaz:
https://doaj.org/article/48ef8d8e095e44dc8505eb4a20c9e793
Autor:
Qiu-Ying Han, Yuan Chen, Li Ailing, Na Wang, Zeng-Lin Guo, Tao Zhou, Zhao-Shan Liu, Kun He, Hong Cai, Tao Li, Jiang-Man Zhao, Xue-Min Zhang, Feng Zhang, Tian Xia, Liang Chen, Wen Xue, Jie Mao, Weihua Li, Xin Liu, Li-Ming Sun
Publikováno v:
The Journal of Immunology. 206:2453-2467
The detection of intracellular nucleic acids is a fundamental mechanism of host defense against infections. The dysregulated nucleic acid sensing, however, is a major cause for a number of autoimmune diseases. In this study, we report that GTPase-act
Autor:
Fan Qiao, Yi Chen, Le Diao, Feng Zhao, Yu-Feng Guo, Shou-Xin Wu, Kai-Lian Zheng, Ying Xu, Gang Jin, Li-Bing Wang, Xiang-Yu Kong, Fang-Zheng Ning, Xiao-Jian Wan, Yue-Qian Zhong, Jiang-Man Zhao, Jia-Huan Zhou, Yu-Chao Dong
Publikováno v:
Aging (Albany NY)
In this retrospective study we assessed the efficacy and safety of tocilizumab in patients with critical or severe coronavirus disease 2019 (COVID-19). We enrolled 181 patients admitted to Huoshenshan Hospital (Wuhan, China) with confirmed COVID-19 b
Autor:
Jiaqi Wu, Yan Huang, Tao Li, Jiang-Man Zhao, Ailing Li, Qiu-Ying Han, Luye Lv, Weiwei Yan, Xiaomin Ying, Yuan Chen, Xiaohong Yao, Qing Xia, Xuemin Zhang, Tian Xia, Feng Gu, Liang Chen, Teng Li, Wan-Jin Li, Ming Zhao, Tao Zhou
Publikováno v:
Cell Death & Disease
Cell Death and Disease, Vol 10, Iss 6, Pp 1-13 (2019)
Cell Death and Disease, Vol 10, Iss 6, Pp 1-13 (2019)
Triple-negative breast cancer (TNBC), defined by the lack of expression of estrogen, progesterone, and ERBB2 receptors, has the worst prognosis of all breast cancers. It is difficult to treat owing to a lack of effective molecular targets. Here, we r